Skip to main content

Kryger Capital LLC

SEC CIK
0002123957
Latest filing
Aug 14, 2026

The latest 13F from Kryger Capital LLC covers Q2 2026 (filed Aug 14, 2026): 109 long positions worth $1.75B. The top 10 holdings make up 74.9% of the portfolio, and the largest is Norfolk Southern Corp (NSC) at 13.8%. Livermore has 2 filings on Form 13F from this institution, going back to Q1 2026.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
72
Est. +$421.4M
Added
20
Est. +$435.6M
Reduced
17
Est. −$16.1M
Sold out
39
Est. −$533.4M

Top 5 holdings

Share of this quarter's portfolio value

  1. NSCNorfolk Southern Corp
    13.8%$241.1MHistory
  2. GTLSChart Industries Inc
    10.6%$186.5MHistory
  3. KVUEKenvue Inc.
    9.3%$163.4MHistory
  4. DBRGDigitalBridge Group, Inc.
    8.1%$142.1MHistory
  5. EAElectronic Arts Inc.
    8.0%$140.8MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. APGEApogee Therapeutics, Inc.
    +$98.6MNewHistory
  2. NSCNorfolk Southern Corp
    +$74.2MAddedHistory
  3. GTLSChart Industries Inc
    +$71.6MAddedHistory
  4. AESAES Corp
    +$67.3MAddedHistory
  5. KVUEKenvue Inc.
    +$63.8MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. APGEApogee Therapeutics, Inc.
    +5.62 pp0.0% → 5.6%History
  2. AESAES Corp
    +3.48 pp2.2% → 5.7%History
  3. ROKURoku, Inc
    +3.27 pp0.0% → 3.3%History
  4. NSCNorfolk Southern Corp
    +2.99 pp10.8% → 13.8%History
  5. KVUEKenvue Inc.
    +2.97 pp6.4% → 9.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CWANClearwater Analytics Holdings, Inc.
    −$90.3MSold outHistory
  2. DAWNDay One Biopharmaceuticals, Inc.
    −$83.5MSold outHistory
  3. FOLDAmicus Therapeutics, Inc.
    −$65.9MSold outHistory
  4. HOLXHologic Inc
    −$62.1MSold outHistory
  5. ALSumisho Air Lease Corp
    −$57.0MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CWANClearwater Analytics Holdings, Inc.
    −6.38 pp6.4% → 0.0%History
  2. DAWNDay One Biopharmaceuticals, Inc.
    −5.91 pp5.9% → 0.0%History
  3. FOLDAmicus Therapeutics, Inc.
    −4.66 pp4.7% → 0.0%History
  4. HOLXHologic Inc
    −4.39 pp4.4% → 0.0%History
  5. ALSumisho Air Lease Corp
    −4.03 pp4.0% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.75B
+$338.5M (+23.9%) vs. prior quarter
Positions
109
+33 vs. prior quarter
Top 10 concentration
74.9%
Top 10 as share of value
Turnover
34.7%
Q2 2026, one quarter
Average holding period
1.8 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2026), so positions held before then are understated.

13F filings by quarter

2 quarters, going back to Q1 2026. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.75B (Q2 2026)

Q1 2026: $1.41BQ2 2026: $1.75B
Q1 2026Q2 2026
13F filings of Kryger Capital LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026109$1.75BNSCGTLSKVUEvs. Q1 2026SEC
Q1 2026May 14, 202676$1.41BNSCGTLSEA–SEC